We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Indian Court Temporarily Blocks Glenmark’s Generic Diabetes Drugs
Indian Court Temporarily Blocks Glenmark’s Generic Diabetes Drugs
India’s Supreme Court has temporarily barred Glenmark Pharmaceuticals from making new copies of Merck’s diabetes drugs Januvia and Janumet, but the Mumbai-based company may continue to sell its existing stock.